Introduction
The impressive outcomes following radical D2 gastrectomy for gastric cancer in large retrospective series from Japan [1] [2] [3] [4] have not been reproduced in randomized comparative studies from Europe [5] [6] [7] [8] . It is assumed widely and asserted confidently at scientific meetings that this discrepancy in outcomes after D2 gastrectomy for gastric cancer is due to the greater age, comorbidity, advanced stages of disease, and greater body mass indices (overweight with deep abdominal cavities) of Western patients when compared with patients in Japan [9, 10] . Furthermore, a recent report from Japan concluded that a higher body mass index (BMI) hampered lymphadenectomy in gastric cancer patients, and was an independent predictor of cancer recurrences [11] .
Obesity is becoming more prevalent, with 15% to 20% of individuals in Europe fulfilling the criteria of a BMI of greater than 30kgm Ϫ2 , and the situation is far worse in the United States of America [12] [13] [14] . Surgery and anesthesia are more hazardous in patients who are overweight, not least because of the increased incidence of cardiorespiratory comorbidity [15] . Moreover, lymphadenectomy remains a painstaking procedure when extended beyond the D1 level and is not without risk in its own right [5, 6] .
The aim of this study, therefore, was to examine the relationship between BMIs American Society of Anesthesiology (ASA) grades, operative times, and outcomes after modified D2 gastrectomy (preserving pancreas and spleen where possible) for gastric cancer. The setting was a large acute district general hospital in South Wales serving a population of 480000. 
Patients and methods

Between
Surgical treatment
Since 1995, our policy has been to perform a modified radical D2 resection with extended lymphadenectomy, but preserving the pancreas and spleen where possible, as described by Sue-Ling et al. [9] and Griffith et al. [10] . Preoperative staging was done with the aid of both spiral computerized tomography and laparoscopy. All tumors were staged in accordance with the 1987 Unified classification of gastric cancer [16] , until 1997, when we adopted the recently published TNM Classification of malignant tumours [17] . The details of the patients undergoing potentially curative resection, together with their ASA grade and stage of disease, are shown in Table 1 . The patients' preoperative BMIs were calculated at either their initial outpatients' consultation or by our dietetics team as an inpatient, if admitted with an acute complication (n ϭ 19 patients). Patients with BMIs of greater than 24.7 kgm Ϫ2 for males and 22.6kgm
Ϫ2 for females were classified as overweight, as described by Dhar et al. [11] . Patients with BMIs of less than 20 kgm Ϫ2 were classified as malnourished, and patients with BMIs of greater than 30kgm Ϫ2 were classified as obese, as defined by the guidelines of the World Health Organization [18] . The details of the patients' surgeries are shown in Table 2 . No patients received preoperative neoadjuvant chemotherapy.
Follow-up
Patients were reviewed every 3 months for the first year and every 6 months thereafter. Only 1 of the 84 patients was lost to follow-up and 44 patients were followed-up for a minimum of 5 years or until death. The median duration of follow-up was 36 months (range, 12 to 84 months). Endoscopy and computed tomography were performed if recurrent disease was suspected. Causes of death were sought from case notes, pathology records, and general practitioners' records.
Statistical analysis
Statistical analysis appropriate for nonparametric data was used. Grouped data were expressed as median (interquartile range). Groups were compared with the Mann-Whitney U-test for unpaired data. Cumulative survival was calculated by the life table method of Kaplan and Meier [19] . Differences in survival times between groups of patients were analyzed by the log rank method (20) . Cox's proportional hazards model was used to assess the prognostic value of individual variables (21) . Data analysis was carried out with the 
Results
Details of the patients and stages of disease at presentation (Table 1) The demographic details of patients, together with their ASA grades are shown in Table 1 . There was no correlation between the ASA grades of the patients and their BMIs (r ϭ Ϫ0.093; P ϭ 0.423). The stage of disease was similar irrespective of BMI (r ϭ Ϫ0.126; P ϭ 0.279).
Operative morbidity and mortality (Table 3) Operative morbidity was 26% in overweight patients compared with 22% in controls ( 2 ϭ 0.240; df ϭ 1; P ϭ 0.624). The details of the major operative morbidities are shown in Table 3 . Operative mortality 30 days after operation was 7.9% (3 of 38 patients) in overweight patients compared with 6.5% (3 of 46 patients) of control patients ( 2 ϭ 0.059; df ϭ 1; P ϭ 0.808). None of the patients who died after a D2 gastrectomy had undergone a splenectomy or pancreatectomy.
Influence of extremes of body mass indices
Eleven patients (13%) had a BMI of less than 20 and were classified as malnourished (median age, 69 years; 7 males). Six patients (7%) had BMIs of greater than 30 and were classified as obese (median age, 64 years; 5 males). Of the malnourished patients, 2 patients suffered significant morbidity and 1 of these patients died of a pulmonary embolus ( 2 ϭ 0.217; df ϭ 1; P ϭ 0.641). Obese patients suffered no significant complications ( 2 ϭ 0.331; df ϭ 1; P ϭ 0.565).
Operative time
The median operative times were 260min (range, 160 to 390min) for patients with a high BMI compared with 225min (range, 145 to 355 min) for patients with normal or low BMI (P ϭ 0.094). There was a trend for surgery to take longer in patients with higher BMIs, especially the obese patients; however, this did not correlate significantly (r ϭ 0.123; P ϭ 0.406).
Extent of lymphadenectomy
The median numbers of lymph nodes examined by our pathologists related to BMI were 15 (12-31) nodes in patients with a high BMI compared with 19 (12-32) nodes in patients with a low BMI (P ϭ 0.146). The lymph node ratio (ratio of diseased to removed nodes) was greater than 0.5 in 25% of patients with a high BMI compared with 0% in patients with a low BMI. (Table 4) Fifteen of the patients with a high BMI (39%) developed a recurrence compared with 11 of the patients with a normal or low BMI (24%; 2 ϭ 2.358; df ϭ 1; P ϭ 0.125). The pattern of this recurrence did not differ significantly between the groups. Local recurrence was slightly more common in patients with a normal or low BMI (13.0%) compared with patients with a high BMI (10.5%; 2 ϭ 0.126; df ϭ 1; P ϭ 0.723).
Recurrence patterns after R0 resections for gastric cancer related to body mass indices
Survival
The corrected cumulative survival related to BMIs, calculated by life-table analysis, is shown in Fig. 1 . Cumulative survival for the 38 patients with a high BMI was 52% at 5 years compared with 55% for patients with a normal or low BMI ( 2 ϭ 0.15; df ϭ 1; P ϭ 0.7002). The factors found to be significantly associated with the duration of survival on univariate analysis are shown in Table 5 . 
Multivariate analysis
The prognostic variables entered into the equation were age, sex, BMI, stage of the tumor, location of the tumor, type of gastrectomy (total or subtotal), and level of the resection of the spleen and pancreas. Forward and backward stepwise regression were used. The number of lymph node metastases (hazard ratio, 1.441; 95% confidence interval [CI] 1.159-1.723; P ϭ 0.009), and splenectomy (hazard ratio, 12.111; 95% CI, 9.645-14.577; P ϭ 0.043) were found to be the most important predictors of outcome as determined by Cox's proportional hazards model (global 2 for the model was 10.13; df ϭ 2; P ϭ 0.006).
Discussion
Body mass indices (BMIs) have been implicated as an important prognostic indicator in all the common cancers of the Western world, including lung, breast, gastric, and colonic carcinoma [11, [22] [23] [24] . The principal findings of this study were that no fewer than 45% of our gastric cancer patients were overweight and 7% were obese. Operative times tended to be longer in patients who were overweight when compared with our control patients, reflecting the more demanding nature of the lymphadenectomy, but the extent of the lymphadenectomy was not compromised. Operative morbidity and mortality were not increased in patients who were overweight compared with patients with a normal or low BMI, and their duration of survival was similar.
Despite sporadic reports to the contrary, the prognosis for patients with gastric cancer in Britain and much of the West remains poor. The longstanding debate over the ideal extent of the lymphadenectomy required remains unresolved, with the excellent results of radical surgery in large retrospective series from Japan [1] [2] [3] [4] unmatched in randomized comparative series from Europe [5] [6] [7] [8] , where more radical surgery has resulted in a higher incidence of fatal complications without any survival benefit. Thus, most Western surgeons continue to perform a traditional D1 gastrectomy. The longstanding belief that advantageous tumor characteristics in Japanese patients might be responsible for the apparent survival advantages reported in Japanese series [24] has recently been challenged by the demonstration that Japanese patients with gastric cancer actually have worse characteristics than Western patients [25] . Racial factors notwithstanding, the clear difference between patients with gastric cancer in the West and those in Japan is their respective BMIs [26] . In the recent study by Dhar et al. [11] , only 11% of a series of 787 patients in Japan was classified as overweight. Patients with a high BMI had longer operative times and a greater postoperative morbidity, at 34%, compared with 20% in patients with a low BMI. The operative mortalities reported by Dhar et al. in these groups of patients were 6.5% in overweight patients and 3.1% in patients with a low BMI. Our own morbidity figures are similar to those of Dhar et al. at 26% and 22%, respectively, although our operative mortality figures are clearly higher, at 7.9% in overweight patients compared with 6.5% in patients with a low BMI.
Lymphadenectomy in patients with gastric cancer is undoubtedly a painstaking surgical procedure, especially when extended beyond the perigastric D1 level. Moreover, extended D2 lymphadenectomy is reported to carry an even greater and significant associated risk when performed with an en-bloc resection of the spleen and pancreas as part of the classical radical D2 gastrectomy [5] [6] [7] [8] . Although most of the perigastric lymph nodes can be resected en-bloc with the stomach, the N2 and N3 regional lymph nodes lie deep within the fatty mesentery around the major abdominal vessels. An excess of fatty tissue here necessitates a more complex dissection, which can on occasion be associated with troublesome hemorrhage. Dhar et al. [11] reported that overweight patients underwent an apparently unsuccessful lymphadenectomy when compared with patients with low BMIs, and had a higher ratio of diseased-to-removed lymph nodes, irrespective of other prognostic factors. Anatomical dissections by Wagner et al. [27] revealed that a mean of 27 lymph nodes could be recovered during a D2 level dissection. Siewert et al. [28] set the criteria for a D2 lymphadenectomy as greater than 25 lymph nodes removed. Dhar et al. [11] reported a mean lymph node count of 21 Ϯ 9 in patients with a high BMI compared with 28 Ϯ 14 in patients with a low BMI. However, to our knowledge, there is no report on the number of lymph nodes retrieved during a modified D2 gastrectomy preserving spleen and pancreas where possible. Certainly in our series fewer lymph nodes were recovered by our pathologists; however, we would add the caveat that lymph node counts were dependent on individual pathologists and were greater when an immediate postoperative off-table lymphadenectomy was performed and the specimens were examined by our specialist pathologist. Moreover, the lower number of recovered lymph nodes did not translate into worse outcomes; our rates of recurrence, as well as the overall cumulative 5-year survival of 52% and 55% in patients with high and low BMIs, respectively, stand comparison with those described by Dhar et al., of 63% and 72%, respectively.
In conclusion, almost half of our patients were overweight by the criteria described by Dhar et al. [11] , and one-third of our patients were overweight by World Health Organization criteria [18] . Lymphadenectomy was clearly more difficult in patients with a high BMI compared with patients with a normal or low BMI, as reflected in longer operative times. Nevertheless, operative morbidity and mortality were similar and local recurrence no more likely in overweight patients compared with the control patients. The findings of this study lend further support to the performance of a modified D2 gastrectomy, preserving the pancreas and spleen where possible, by specialist surgeons within the framework of multidisciplinary teams.
